Long-chain fatty acid uptake into adipocytes depends on lipid raft function

Biochemistry. 2004 Apr 13;43(14):4179-87. doi: 10.1021/bi035743m.

Abstract

This study investigates the role of lipid rafts and caveolae, a subclass of lipid raft microdomains, in the binding and uptake of long-chain fatty acids (LCFA) by 3T3-L1 cells during differentiation. Disruption of lipid rafts by beta-cyclodextrin (betaCD) or selective inhibition of caveolae by overexpression of a dominant-negative mutant of caveolin-3 (Cav(DGV)) resulted in disassembly of caveolae structures at the cell surface, as assessed by electron microscopy. While in 3T3-L1 fibroblasts, which express few caveolae, Cav(DGV) or betaCD had no effect on LCFA uptake, in 3T3-L1 adipocytes the same treatments decreased the level of [(3)H]oleic acid uptake by up to 55 +/- 8 and 49 +/- 7%, respectively. In contrast, cholesterol loading of 3T3-L1 adipocytes resulted in a 4-fold increase in the extent of caveolin-1 expression and a 1.7-fold increase in the level of LCFA uptake. Both the inhibitory and enhancing effects of these treatments were constantly increasing with the [(3)H]oleic acid incubation time up to 5 min. Incubation of 3T3-L1 adipocytes with [(3)H]stearate followed by isolation of a caveolin-1 positive detergent-resistant membrane (DRM) fraction revealed that [(3)H]stearate binds to caveolae. Fatty acid translocase (FAT/CD36) was found to be present in this DRM fraction as well. Our data thus strongly indicate a critical involvement of lipid rafts in the binding and uptake of LCFA into 3T3-L1 adipocytes. Furthermore, our findings suggest that caveolae play a pivotal role in lipid raft-dependent LCFA uptake. This transport mechanism is induced in conjunction with cell differentiation and might be mediated by FAT/CD36.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / metabolism*
  • Animals
  • Binding Sites
  • CD36 Antigens / metabolism
  • Caprylates / metabolism
  • Caveolae / drug effects
  • Caveolae / metabolism
  • Caveolin 3
  • Caveolins / biosynthesis
  • Caveolins / genetics
  • Caveolins / pharmacology
  • Cholesterol / metabolism
  • Cholesterol / pharmacology
  • Cholic Acids / pharmacology
  • Cyclodextrins / pharmacology
  • Detergents / pharmacology
  • Fatty Acids / metabolism*
  • Membrane Microdomains / drug effects
  • Membrane Microdomains / metabolism
  • Membrane Microdomains / physiology*
  • Mice
  • Oleic Acid / metabolism
  • Stearic Acids / metabolism
  • beta-Cyclodextrins*

Substances

  • CD36 Antigens
  • Caprylates
  • Cav3 protein, mouse
  • Caveolin 3
  • Caveolins
  • Cholic Acids
  • Cyclodextrins
  • Detergents
  • Fatty Acids
  • Stearic Acids
  • beta-Cyclodextrins
  • Oleic Acid
  • stearic acid
  • Cholesterol
  • betadex
  • octanoic acid
  • 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate